[go: up one dir, main page]

SI0904774T1 - Resorcinol derivatives - Google Patents

Resorcinol derivatives

Info

Publication number
SI0904774T1
SI0904774T1 SI9830403T SI9830403T SI0904774T1 SI 0904774 T1 SI0904774 T1 SI 0904774T1 SI 9830403 T SI9830403 T SI 9830403T SI 9830403 T SI9830403 T SI 9830403T SI 0904774 T1 SI0904774 T1 SI 0904774T1
Authority
SI
Slovenia
Prior art keywords
resorcinol derivatives
resorcinol
derivatives
Prior art date
Application number
SI9830403T
Other languages
English (en)
Slovenian (sl)
Inventor
Lan Hu
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of SI0904774T1 publication Critical patent/SI0904774T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
SI9830403T 1997-09-23 1998-09-16 Resorcinol derivatives SI0904774T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5962597P 1997-09-23 1997-09-23
EP98307523A EP0904774B1 (fr) 1997-09-23 1998-09-16 Dérivés de resorcinol

Publications (1)

Publication Number Publication Date
SI0904774T1 true SI0904774T1 (en) 2003-10-31

Family

ID=22024176

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830403T SI0904774T1 (en) 1997-09-23 1998-09-16 Resorcinol derivatives

Country Status (45)

Country Link
US (1) US6132740A (fr)
EP (1) EP0904774B1 (fr)
JP (2) JP3591763B2 (fr)
KR (1) KR100373996B1 (fr)
CN (1) CN1176647C (fr)
AP (1) AP857A (fr)
AR (1) AR012520A1 (fr)
AT (1) ATE235220T1 (fr)
AU (1) AU735716C (fr)
BG (1) BG64524B1 (fr)
BR (1) BR9803596A (fr)
CA (1) CA2247748C (fr)
CO (1) CO5070677A1 (fr)
CZ (1) CZ297669B6 (fr)
DE (1) DE69812519T2 (fr)
DK (1) DK0904774T3 (fr)
DZ (1) DZ2614A1 (fr)
EA (1) EA003576B1 (fr)
EG (1) EG23860A (fr)
ES (1) ES2192301T3 (fr)
GT (1) GT199800150A (fr)
HR (1) HRP20000168B1 (fr)
HU (1) HUP0003743A3 (fr)
ID (1) ID24084A (fr)
IL (2) IL134598A0 (fr)
IS (1) IS2280B (fr)
MA (1) MA26548A1 (fr)
MY (1) MY117805A (fr)
NO (1) NO327177B1 (fr)
NZ (1) NZ502797A (fr)
OA (1) OA11334A (fr)
PA (1) PA8459901A1 (fr)
PE (1) PE117299A1 (fr)
PL (1) PL195192B1 (fr)
PT (1) PT904774E (fr)
SA (1) SA98190724B1 (fr)
SI (1) SI0904774T1 (fr)
SK (1) SK284983B6 (fr)
TN (1) TNSN98176A1 (fr)
TR (1) TR200000782T2 (fr)
TW (1) TW585780B (fr)
UA (1) UA57106C2 (fr)
UY (2) UY25191A1 (fr)
WO (1) WO1999015148A1 (fr)
ZA (1) ZA988669B (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6414037B1 (en) * 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
FR2777183B1 (fr) * 1998-04-10 2001-03-02 Oreal Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
HN2000000033A (es) * 1999-03-22 2001-02-02 Pfizer Prod Inc Composicion de resorcinol
US6878381B2 (en) * 1999-03-22 2005-04-12 Pfizer, Inc Resorcinol composition
SI1165495T1 (en) * 1999-03-22 2005-08-31 Pfizer Resorcinol derivatives
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
US20020034772A1 (en) * 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
EP1134207A1 (fr) * 2000-03-15 2001-09-19 Pfizer Products Inc. Procédé pour la préparation de dérivés du résorcinol
IT1318425B1 (it) * 2000-03-24 2003-08-25 D B P Dev Biotechnological Pro Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
JP4615671B2 (ja) * 2000-04-20 2011-01-19 ポーラ化成工業株式会社 炎症存在下使用用のしわ形成又は皮膚の弾力喪失の防止剤
BR0113798A (pt) * 2000-09-11 2003-07-08 Pfizer Prod Inc Derivados de resorcinol
BR0114059A (pt) * 2000-09-21 2003-07-01 Pfizer Prod Inc Derivados de resorcinol
US6514506B1 (en) * 2001-02-14 2003-02-04 Color Access, Inc. Whitening compositions containing ascomycete derived enzyme
EP1383493A4 (fr) 2001-05-02 2005-09-21 Univ New York Inhibition de la pigmentation par l'inhibition de l'acide gras synthase
EP1392673B1 (fr) * 2001-05-25 2005-06-08 Wella Aktiengesellschaft Derives de 1,3-dihydroxybenzene et colorants contenant ces composes
US6863897B2 (en) * 2002-03-22 2005-03-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Stabilization of resorcinol derivatives in cosmetic compositions
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
WO2003095645A1 (fr) * 2002-05-09 2003-11-20 New York University Essai pour la melanogenese
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US6852310B2 (en) * 2002-08-23 2005-02-08 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
US7524485B2 (en) * 2002-12-12 2009-04-28 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US6875425B2 (en) * 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
BRPI0407193A (pt) * 2003-02-03 2006-02-14 Warner Lambert Co formulação aperfeiçoada para agentes de clareamento da pele
US7338979B2 (en) * 2003-02-11 2008-03-04 Warner-Lambert Company Depigmentation agents
BRPI0410288A (pt) * 2003-05-20 2006-05-16 Warner Lambert Co agentes de despigmentação
JP2006528239A (ja) * 2003-05-26 2006-12-14 エンプラニ シーオー．，エルティーディ． レスベラトロルを含有する、美白及び抗酸化作用を有する化粧料組成物、並びに、その製造方法
AU2004253579B2 (en) 2003-07-01 2010-12-23 Biomol International L.P. Sirt1 modulators for manipulating cells/organism lifespan/stress response
CN100439307C (zh) * 2003-07-08 2008-12-03 荷兰联合利华有限公司 化妆活性物质的制备方法
US20050171027A1 (en) 2003-12-29 2005-08-04 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US7300646B2 (en) * 2004-02-27 2007-11-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
PL1748767T3 (pl) 2004-05-28 2012-08-31 Unigen Inc 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy
DE602004026647D1 (de) * 2004-09-14 2010-05-27 Ajinomoto Omnichem S A Topische zusammensetzungen mit phosphorylierten polyphenolen
JP5093998B2 (ja) * 2004-09-22 2012-12-12 大塚製薬株式会社 色素沈着予防又は改善剤
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
WO2006138418A2 (fr) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Amelioration de la performance cognitive avec des activateurs de sirtuine
JP5244400B2 (ja) * 2005-12-26 2013-07-24 株式会社林原 アルキルレゾルシノール配糖体とその製造方法並びに用途
WO2007077259A1 (fr) * 2006-01-05 2007-07-12 Symrise Gmbh & Co. Kg Preparations actives synergiques comprenant des derives de diphenylmethane et en outre des composes reduisant l'eclaircissement de la peau et/ou des cheveux et/ou la keratose senile
US7247294B1 (en) 2006-03-30 2007-07-24 Conopco, Inc. Skin lightening agents, compositions and methods
US7270805B1 (en) 2006-03-30 2007-09-18 Conopco, Inc. Skin lightening agents, compositions and methods
US7250158B1 (en) 2006-03-30 2007-07-31 Conopco, Inc. Skin lightening agents, compositions and methods
RU2428167C2 (ru) * 2006-06-19 2011-09-10 Курарей Ко., Лтд. Препарат для наружного нанесения на кожу, обладающий повышенной стабильностью
JP5132095B2 (ja) * 2006-07-13 2013-01-30 ポーラ化成工業株式会社 エマルション剤形の皮膚外用剤
JP4990574B2 (ja) * 2006-07-13 2012-08-01 ポーラ化成工業株式会社 新規化合物及びそれを含有する皮膚外用剤
DE102007038097A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
DE102007038098A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
WO2009064492A1 (fr) * 2007-11-14 2009-05-22 New York University School Of Medicine Composés de quinoline à titre de modificateurs de mélanogenèse et leurs utilisations
WO2009064493A1 (fr) * 2007-11-14 2009-05-22 New York University School Of Medicine Composés tricycliques en tant que modificateurs de la mélanogenèse et leurs utilisations
US20100040568A1 (en) * 2008-04-30 2010-02-18 Skinmedica, Inc. Steroidal compounds as melanogenesis modifiers and uses thereof
US20100010100A1 (en) * 2008-07-09 2010-01-14 Hinman Andrew W Dermatological compositions with anti-aging and skin even-toning properties
ES2998662T3 (en) * 2008-07-21 2025-02-21 Unigen Inc Skin-whitening (lightening) compounds
US20100029784A1 (en) * 2008-07-30 2010-02-04 Hinman Andrew W Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939136B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2953834B1 (fr) 2009-12-10 2012-01-13 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
JP4825921B1 (ja) * 2010-07-16 2011-11-30 株式会社 資生堂 ４−アルキルレゾルシノール誘導体及びこれを含有する皮膚外用剤
WO2012103487A1 (fr) 2011-01-27 2012-08-02 New York University Composés de coumarine utilisés comme modificateurs de mélanogenèse et leurs utilisations
KR102257469B1 (ko) 2011-03-24 2021-05-27 유니젠, 인크. 디아릴프로판의 제조를 위한 화합물 및 방법
EP2964182B1 (fr) 2013-03-08 2018-02-14 Unilever PLC, a company registered in England and Wales under company no. 41424 of Composés résorcinols pour un usage dermatologique
RU2582215C1 (ru) * 2015-01-16 2016-04-20 Александр Ливиевич Ураков Способ обесцвечивания кожи в области кровоподтека
WO2017079905A1 (fr) * 2015-11-10 2017-05-18 Henkel Ag & Co. Kgaa Composition cosmétique pour l'éclaircissement de la peau
WO2017215863A1 (fr) 2016-06-15 2017-12-21 Unilever N.V. Procédé et composition cosmétique pour une meilleure administration transdermique de résorcinol substitué par un alkyle
KR102667506B1 (ko) * 2016-06-30 2024-05-20 시므라이즈 아게 레조르시놀 유도체를 포함하는 약제 및 화장품 조성물
EA201992520A1 (ru) * 2017-07-12 2020-06-25 Юнилевер Н.В. Масло, улучшающее композицию для кожи
IT201700104536A1 (it) 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico
EP3996664B1 (fr) 2019-07-12 2024-08-21 Unilever Global IP Limited Stabilisation de composés de résorcinol dans des compositions cosmétiques
EP4051225A4 (fr) * 2019-10-30 2023-07-19 Dow Global Technologies LLC Compositions de soins solaires comprenant des nanosphères de silice mésoporeuse creuses
US20230165772A1 (en) 2020-04-28 2023-06-01 Conopco, Inc., D/B/A Unilever Stabilized cosmetic compositions with n, n'-di-acetyl cystine
CN114315527B (zh) * 2021-12-29 2024-06-11 苏州博研医药科技有限公司 一种间苯二酚的制备方法
CN120826212A (zh) 2022-12-21 2025-10-21 联合利华知识产权控股有限公司 具有吲哚的配方的颜色稳定化
WO2025140839A1 (fr) 2023-12-29 2025-07-03 Unilever Ip Holdings B.V. Stabilisation de couleur de formules avec du nitrure de bore
WO2025225705A1 (fr) * 2024-04-25 2025-10-30 国立大学法人富山大学 Promoteur de décomposition de mélanine et inhibiteur de production de mélanine

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1131200A (en) * 1966-06-06 1968-10-23 Fuji Photo Film Co Ltd Process for the production of polymer images by the polymerization of vinyl compounds
BE713299A (fr) * 1967-04-06 1968-08-16
US3933925A (en) * 1972-06-29 1976-01-20 Koppers Company, Inc. Hydrolysis of toluene diamines to produce methyl resorcinols
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
DE2616479C2 (de) * 1976-04-14 1986-12-04 Brickl, Rolf, Dr., 7951 Warthausen Substituierte Fluoracylresorcine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel und Kosmetika
DE3127590A1 (de) * 1980-07-12 1982-08-12 Kozak, Pavel, 6600 Saarbrücken Mittel fuer die externe behandlung von hautkrakheiten
US4391827A (en) * 1980-09-08 1983-07-05 Pfizer Inc. 3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor
US4526179A (en) * 1983-01-28 1985-07-02 Leonard Salesky Digital apical foramen locating apparatus
DE3604865A1 (de) * 1986-02-15 1987-08-20 Walter Dr Med Langbehn Haut-kosmetikum
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
US4985157A (en) * 1989-05-01 1991-01-15 Mobil Oil Corporation Mixed alkoxylated alcohol-hydroquinone/resorcinol borates-antioxidants
US5059438A (en) * 1990-02-05 1991-10-22 Enzytech, Inc. Compositions and methods for inhibiting browning in foods using resorcinol derivatives
JPH054905A (ja) * 1990-10-31 1993-01-14 Pola Chem Ind Inc 化粧料
JP2801960B2 (ja) * 1990-10-31 1998-09-21 ポーラ化成工業株式会社 頭髪化粧料
JP2875374B2 (ja) * 1990-10-31 1999-03-31 ポーラ化成工業株式会社 ニキビ用化粧料
FR2679133B1 (fr) * 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
EP0524439A1 (fr) * 1991-07-24 1993-01-27 F.Hoffmann-La Roche & Co. Aktiengesellschaft Dérivés du cyclohexane et du tétrahydropyranne et compositions antifongiques contenant ces dérivés
SK280617B6 (sk) * 1992-01-16 2000-05-16 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, spôsob ich prípravy, f
CA2094465A1 (fr) * 1992-04-23 1993-10-24 Pierre Andre Raymond Bruneau Derives de cycloalcane
US5399785A (en) * 1992-08-05 1995-03-21 Nippon Paint Co., Ltd. Tyrosinase activity inhibitor
JPH0656641A (ja) * 1992-08-05 1994-03-01 Nippon Paint Co Ltd 化粧料
FR2704428B1 (fr) * 1993-04-29 1995-06-09 Oreal Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante.
FR2704753B1 (fr) * 1993-05-06 1995-06-30 Oreal Utilisation de derives de la 4-thio resorcine ou 4-thio 1-3-dihydroxybenzene, dans des compositions cosmetiques ou dermopharmaceutiques a action depigmentante.
GB9418762D0 (en) * 1994-09-16 1994-11-02 Bayer Ag Use of substituted cyclopentane-DI-and-triones
JP2790986B2 (ja) * 1995-02-27 1998-08-27 住友建設株式会社 橋脚の構築方法及び施工方法

Also Published As

Publication number Publication date
SK3782000A3 (en) 2001-06-11
AU8994698A (en) 1999-04-12
BG64524B1 (bg) 2005-06-30
NO327177B1 (no) 2009-05-04
DE69812519D1 (de) 2003-04-30
TNSN98176A1 (fr) 2005-03-15
MY117805A (en) 2004-08-30
PE117299A1 (es) 1999-11-18
TR200000782T2 (tr) 2000-09-21
HUP0003743A2 (hu) 2001-04-28
MA26548A1 (fr) 2004-12-20
CA2247748A1 (fr) 1999-03-23
HRP20000168A2 (en) 2000-08-31
NZ502797A (en) 2002-04-26
EP0904774B1 (fr) 2003-03-26
EP0904774A1 (fr) 1999-03-31
OA11334A (en) 2003-12-10
ID24084A (id) 2000-07-06
IS5376A (is) 2000-02-15
IS2280B (is) 2007-09-15
UA57106C2 (uk) 2003-06-16
AP857A (en) 2000-07-11
PL339551A1 (en) 2000-12-18
CO5070677A1 (es) 2001-08-28
BR9803596A (pt) 2000-04-25
AP9801349A0 (en) 1998-09-30
HK1028344A1 (en) 2001-02-16
IL134598A0 (en) 2001-04-30
AR012520A1 (es) 2000-10-18
EA200000251A1 (ru) 2000-08-28
TW585780B (en) 2004-05-01
CZ20001037A3 (cs) 2001-02-14
PT904774E (pt) 2003-08-29
KR100373996B1 (ko) 2003-02-26
AU735716C (en) 2007-03-29
PL195192B1 (pl) 2007-08-31
SK284983B6 (sk) 2006-03-02
JPH11152203A (ja) 1999-06-08
JP2004210799A (ja) 2004-07-29
EA003576B1 (ru) 2003-06-26
HUP0003743A3 (en) 2006-02-28
US6132740A (en) 2000-10-17
CN1176647C (zh) 2004-11-24
ZA988669B (en) 2000-03-22
DE69812519T2 (de) 2003-12-11
PA8459901A1 (es) 2000-05-24
UY25550A1 (es) 2000-02-23
UY25191A1 (es) 2001-08-27
DK0904774T3 (da) 2003-06-16
CN1270509A (zh) 2000-10-18
JP3591763B2 (ja) 2004-11-24
SA98190724B1 (ar) 2006-05-20
NO20001473L (no) 2000-03-22
ES2192301T3 (es) 2003-10-01
ATE235220T1 (de) 2003-04-15
HRP20000168B1 (en) 2006-07-31
WO1999015148A1 (fr) 1999-04-01
DZ2614A1 (fr) 2003-03-01
IL170545A (en) 2010-04-29
GT199800150A (es) 2000-03-15
BG104247A (en) 2000-11-30
AU735716B2 (en) 2001-07-12
KR20010024217A (ko) 2001-03-26
CZ297669B6 (cs) 2007-02-28
EG23860A (en) 2007-11-18
CA2247748C (fr) 2002-07-02
NO20001473D0 (no) 2000-03-22

Similar Documents

Publication Publication Date Title
EG23860A (en) Resorcinol derivatives
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
PL346155A1 (en) 1h-imidazopyridine derivatives
PL345540A1 (en) Thiobenzimidazole derivatives
HRP990011B1 (en) Benzosulfone derivatives
GB9809664D0 (en) a-Ketoamide derivatives
HUP9801168A3 (en) Triazinylaminostilbene derivatives
EG23802A (en) 2-Phenylpyran-4-one derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
GB9827729D0 (en) Thieno-indole derivatives
ZA98611B (en) Imino-aza-anthracyclinone derivatives
ZA983116B (en) Arylsecocholadiene derivatives
EP1061912A4 (fr) Derives de phenanthrofuran
HU9800889D0 (en) New naphtylpiperazine derivatives
IL139276A0 (en) Cyclohexenondioxthio chromanoyl derivatives
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
SI1005445T1 (en) N-alkanoylphenylalanine derivatives